SEPTEMBER 2024:
Loma joins the Venture House Program at BII.
We are thrilled to announce that Loma has been selected to join the Venture House program at the BioInnovation Institute (BII)! This opportunity marks a significant milestone in our mission to develop the best-in-class therapeutic vaccine targeting HPV-positive cancers, a crucial step in the fight against cancer.
The Venture House program at BII will provide us with invaluable resources, mentorship, and access to a network of experts dedicated to advancing health innovations. At BII, we will have access to world-class facilities, strategic guidance, and a collaborative community focused on making a meaningful impact in healthcare.
Over the coming 18 months, our team will work closely with BII mentors and industry leaders to accelerate the development and testing of our therapeutic vaccine. This program will allow us to advance our technology and bring us closer to offering a solution that could change the landscape for HPV+ cancer treatment.
Stay tuned as we share our progress and updates from our journey in the Venture House program and join us as we take strides toward improving outcomes for patients impacted by HPV-related cancers.
About BioInnovation Institute (BII):
The BioInnovation Institute is an international life science incubator in Denmark that supports startups and research projects focused on creating real-world health and sustainability solutions. Through programs like Venture House, BII aims to empower the next generation of companies to shape a healthier, more sustainable future.